These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

177 related items for PubMed ID: 10854902

  • 1. LY377770, a novel iGlu5 kainate receptor antagonist with neuroprotective effects in global and focal cerebral ischaemia.
    O'Neill MJ, Bogaert L, Hicks CA, Bond A, Ward MA, Ebinger G, Ornstein PL, Michotte Y, Lodge D.
    Neuropharmacology; 2000 Jul 10; 39(9):1575-88. PubMed ID: 10854902
    [Abstract] [Full Text] [Related]

  • 2. Decahydroisoquinolines: novel competitive AMPA/kainate antagonists with neuroprotective effects in global cerebral ischaemia.
    O'Neill MJ, Bond A, Ornstein PL, Ward MA, Hicks CA, Hoo K, Bleakman D, Lodge D.
    Neuropharmacology; 1998 Jul 10; 37(10-11):1211-22. PubMed ID: 9849659
    [Abstract] [Full Text] [Related]

  • 3. NMDA receptor antagonism, but not AMPA receptor antagonism attenuates induced ischaemic tolerance in the gerbil hippocampus.
    Bond A, Lodge D, Hicks CA, Ward MA, O'Neill MJ.
    Eur J Pharmacol; 1999 Sep 10; 380(2-3):91-9. PubMed ID: 10513567
    [Abstract] [Full Text] [Related]

  • 4. Synergistic neuroprotective effects by combining an NMDA or AMPA receptor antagonist with nitric oxide synthase inhibitors in global cerebral ischaemia.
    Hicks CA, Ward MA, Swettenham JB, O'Neill MJ.
    Eur J Pharmacol; 1999 Sep 24; 381(2-3):113-9. PubMed ID: 10554878
    [Abstract] [Full Text] [Related]

  • 5. Neuroprotective effects of 7-nitroindazole in the gerbil model of global cerebral ischaemia.
    O'Neill MJ, Hicks C, Ward M.
    Eur J Pharmacol; 1996 Aug 29; 310(2-3):115-22. PubMed ID: 8884206
    [Abstract] [Full Text] [Related]

  • 6. Neuroprotective effect of YM90K, an AMPA-receptor antagonist, against delayed neuronal death induced by transient global cerebral ischemia in gerbils and rats.
    Kawasaki-Yatsugi S, Yatsugi S, Koshiya K, Shimizu-Sasamata M.
    Jpn J Pharmacol; 1997 Jul 29; 74(3):253-60. PubMed ID: 9268085
    [Abstract] [Full Text] [Related]

  • 7. The novel sigma ligand JO 1994 protects against ischaemia-induced behavioural changes, cell death and receptor dysfunction in the gerbil.
    O'Neill M, Canney M, Earley B, Junien JL, Leonard BE.
    Neurochem Int; 1996 Feb 29; 28(2):193-207. PubMed ID: 8719709
    [Abstract] [Full Text] [Related]

  • 8. Protective effects of vanoxeamine (GBR 12909) against ischaemia-induced hyperactivity and neurodegeneration in the gerbil model of cerebral ischaemia.
    Maginn M, Kelly JP, Leonard BE.
    Pharmacol Biochem Behav; 1997 Apr 29; 56(4):727-35. PubMed ID: 9130300
    [Abstract] [Full Text] [Related]

  • 9. Locomotor activity detects subunit-selective effects of agonists and decahydroisoquinoline antagonists at AMPA/kainic acid ionotropic glutamate receptors in adult rats.
    O'neill MF, Sanger G, Ornstein PL, Osborne DJ, Woodhouse SM.
    Psychopharmacology (Berl); 2005 Apr 29; 179(1):181-8. PubMed ID: 15821949
    [Abstract] [Full Text] [Related]

  • 10. Characterisation of SB-221420-A - a neuronal Ca(2+) and Na(+) channel antagonist in experimental models of stroke.
    Campbell CA, Barone FC, Benham CD, Hadingham SJ, Harries MH, Harling JD, Hills JM, Lewis VA, Mackay KB, Orlek BS, White RF, Parsons AA, Hunter AJ.
    Eur J Pharmacol; 2000 Aug 11; 401(3):419-28. PubMed ID: 10936502
    [Abstract] [Full Text] [Related]

  • 11. AMPA, but not NMDA, receptor antagonism is neuroprotective in gerbil global ischaemia, even when delayed 24 h.
    Sheardown MJ, Suzdak PD, Nordholm L.
    Eur J Pharmacol; 1993 Jun 04; 236(3):347-53. PubMed ID: 7689464
    [Abstract] [Full Text] [Related]

  • 12. Evaluation of glycine site antagonists of the NMDA receptor in global cerebral ischaemia.
    Hicks CA, Ward MA, Ragumoorthy N, Ambler SJ, Dell CP, Dobson D, O'Neill MJ.
    Brain Res; 1999 Feb 20; 819(1-2):65-74. PubMed ID: 10082862
    [Abstract] [Full Text] [Related]

  • 13. LY379268, a potent and selective Group II metabotropic glutamate receptor agonist, is neuroprotective in gerbil global, but not focal, cerebral ischaemia.
    Bond A, Ragumoorthy N, Monn JA, Hicks CA, Ward MA, Lodge D, O'Neill MJ.
    Neurosci Lett; 1999 Oct 08; 273(3):191-4. PubMed ID: 10515191
    [Abstract] [Full Text] [Related]

  • 14. Neuroprotective effects of the AMPA antagonist PNQX in oxygen-glucose deprivation in mouse hippocampal slice cultures and global cerebral ischemia in gerbils.
    Montero M, Nielsen M, Rønn LC, Møller A, Noraberg J, Zimmer J.
    Brain Res; 2007 Oct 26; 1177():124-35. PubMed ID: 17894933
    [Abstract] [Full Text] [Related]

  • 15. LY393615, a novel neuronal Ca(2+) and Na(+) channel blocker with neuroprotective effects in models of in vitro and in vivo cerebral ischemia.
    O'Neill MJ, Hicks CA, Ward MA, Osborne DJ, Wishart G, Mathews KS, McLaughlin DP, Stamford JA, McCarty DR, Patrick KE, Roman C, Fleisch JH, Gilmore J, Boot JR.
    Brain Res; 2001 Jan 05; 888(1):138-149. PubMed ID: 11146060
    [Abstract] [Full Text] [Related]

  • 16. The pre-ischaemic neuroprotective effect of a novel polyamine antagonist, N1-dansyl-spermine in a permanent focal cerebral ischaemia model in mice.
    Li J, Henman MC, Doyle KM, Strbian D, Kirby BP, Tatlisumak T, Shaw GG.
    Brain Res; 2004 Dec 10; 1029(1):84-92. PubMed ID: 15533319
    [Abstract] [Full Text] [Related]

  • 17. The neuronal nitric oxide synthase inhibitor, TRIM, as a neuroprotective agent: effects in models of cerebral ischaemia using histological and magnetic resonance imaging techniques.
    Haga KK, Gregory LJ, Hicks CA, Ward MA, Beech JS, Bath PW, Williams SC, O'Neill MJ.
    Brain Res; 2003 Dec 12; 993(1-2):42-53. PubMed ID: 14642829
    [Abstract] [Full Text] [Related]

  • 18. The neuroprotective effects of the decahydroisoquinoline, LY 215490; a novel AMPA antagonist in focal ischaemia.
    Gill R, Lodge D.
    Neuropharmacology; 1994 Dec 12; 33(12):1529-36. PubMed ID: 7760975
    [Abstract] [Full Text] [Related]

  • 19. Neuroprotective effects of the neuronal Ca(2+) channel blockers, LY042826 and LY393615 in vivo.
    Hicks CA, Ward MA, O'Neill MJ.
    Eur J Pharmacol; 2000 Nov 24; 408(3):241-8. PubMed ID: 11090640
    [Abstract] [Full Text] [Related]

  • 20. The effects of ifenprodil and eliprodil on voltage-dependent Ca2+ channels and in gerbil global cerebral ischaemia.
    Bath CP, Farrell LN, Gilmore J, Ward MA, Hicks CA, O'Neill MJ, Bleakman D.
    Eur J Pharmacol; 1996 Mar 28; 299(1-3):103-12. PubMed ID: 8901012
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.